SCHEMBL6613792

SCHEMBL6613792

c1ccc2nc(OC3CCCC3)ncc2c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 2/20 0.40
CDK2 P24941 2/20 0.40
CDK7 P50613 2/20 0.40
CDK9 P50750 2/20 0.40
CDK1 P06493 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK5 Q00535 1/20 0.39
HRH4 Q9H3N8 2/20 0.39
MKNK2 Q9HBH9 1/20 0.38
PDE9A O76083 1/20 0.38
HCRTR2 O43614 2/20 0.38
HCRTR1 O43613 1/20 0.38
MCHR1 Q99705 2/20 0.37
PDGFRB P09619 2/20 0.37
PDGFRA P16234 2/20 0.37
PDE4A P27815 1/20 0.37
ACACB O00763 1/20 0.37
HTR3A P46098 1/20 0.36
PDE10A Q9Y233 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5663343 0.86 PDE9A (0.47) MKNK2PDE9APDE10A
SCHEMBL29586318 0.84 PDE9A (0.40) HRH4MKNK2PDE9AHCRTR2HCRTR1
SCHEMBL5463861 0.83 HRH4 (0.51) CDK2CDK9HRH4HTR3APDE10A
SCHEMBL8488195 0.82 HCRTR2 (0.35) CDK4CDK2CDK7CDK9CDK1
SCHEMBL2320138 0.80 MKNK2 (0.47) MKNK2PDE9AACACBPDE10A
SCHEMBL30211008 0.80 MKNK2 (0.47) MKNK2PDE9AACACBPDE10A
SCHEMBL2320140 0.80 MKNK2 (0.47) MKNK2PDE9AACACBPDE10A
SCHEMBL1177572 0.78 SLC6A2 (0.52) PDE9AHTR3APDE10A
SCHEMBL1177568 0.78 SLC6A2 (0.52) PDE9AHTR3APDE10A
SCHEMBL22131588 0.77 ACACB (0.55) CDK4CDK2CDK7CDK9CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020211668-A1 CD73 INHIBITORS BIOARDIS LLC (US) 2020-10-22 WO disclosed
WO-2020210938-A1 QUINAZOLINE DERIVATIVES AS CD73 INHIBITORS BIOARDIS LLC (US) 2020-10-22 WO disclosed
EP-1444211-A2 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2004-08-11 EP disclosed
WO-2003040109-A2 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2003-05-15 WO disclosed